Newsletter #3
Welcome to the third edition of the INTEGRATE-HTA newsletter

In this issue, we focus on the ongoing work on integration of relevant aspects in the assessment of complex health technologies and on patient preferences and moderators of treatment outcome. In addition, we would like to inform you on the opportunity to join our External Expert Panel and the tentative timeline for the review of the guidances by this panel. Finally, you can read about our dissemination activities and past events.

Please feel free to forward this newsletter to those who may be interested.

If you have any questions, please do not hesitate to contact us.

The project teamThe INTEGRATE-HTA project team

Integration of relevant aspects in the assessment of complex health technologies
Health Technology Assessment (HTA) is defined by the European network for Health Technology Assessment (EUnetHTA) as a “…multidisciplinary process that summarizes information about the medical, social, economic and ethical aspects related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective health policies that are patient focused and seek to achieve best value.” HTA is an essential tool for health policy decision-making. However, HTAs most often focus primarily on cost and effectiveness parameters. In addition, policy makers are more and more confronted with complex health technologies which aggravate this problem… Read more

The complexity of heterogeneity
A key motive for the INTEGRATE-HTA project is the recognition that the consequences of adopting a healthcare technology may be quite complex. Complexity may derive from multiple effects at different levels, mutual interaction with (changing) contexts, interdependence between different components of the intervention, etc. Such complexity calls for an integrative approach. In Work Package 4 (WP4) of the INTEGRATE-HTA project, two sources of complexity are specifically addressed, both of which may be conceived as an instance of heterogeneity: moderators of treatment effect, and patients' preferences for treatment outcomes... Read more

External Expert Panel  
With the aim of testing the applicability and relevance of the INTEGRATE-HTA project deliverables for broader application, we are establishing an External Expert Panel (EEP). In the previous edition of our newsletter we informed you on the process of establishing the EEP. In this edition we would like to draw your attention to the aim of the EEP and the tentative timeline for the consultation. Please note that there is still an opportunity to join this panel … Read more
Dissemination Activities
Over the last months, project members have presented the INTEGRATE-HTA project at important Palliative Care and HTA conferences, including the 8th World Research Conference of the European Association for Palliative Care (EAPC), the 11th Annual Meeting of Health Technology Assessment international (HTAi), the EUnetHTA conference 2014, and the Ninth biennial INVOLVE conference ... Read more
From 2-6 November 2014 the annual INTEGRATE-HTA project team meeting took place in Rome, Italy. This meeting was hosted by our project partner the Institute of Bioethics of the Università Cattolica del Sacro Cuore. All project partners were represented by up to four representatives and from the advisory board Hindrik Vondeling, University of Southern Denmark, representing EUnetHTA, attended. Much progress was made during the meeting… Read more
The sole responsibility for the content of this newsletter lies with the authors. It does not necessarily reflect the opinion of the European Union. The European Commission is not responsible for any use that
may be made of the information contained therein.
For more in depth information about the INTEGRATE-HTA project or the consortium partners, please visit the INTEGRATE-HTA website.